BioCryst Pharmaceuticals, Inc.【BCRX】 利益剰余金の推移
機能の使い方
|
（単位：百万ドル）
|
利益剰余金
|
前年比（％）
|
|
4Q25
|
-1,507
|
-14.9%
|
|
3Q25
|
-1,753
|
+0.5%
|
|
2Q25
|
-1,765
|
+2.1%
|
|
1Q25
|
-1,771
|
+3.1%
|
|
4Q24
|
-1,771
|
+5.3%
|
|
3Q24
|
-1,744
|
+7.6%
|
|
2Q24
|
-1,730
|
+9.2%
|
|
1Q24
|
-1,717
|
+13.8%
|
|
4Q23
|
-1,682
|
+15.6%
|
|
3Q23
|
-1,620
|
+17.1%
|
|
2Q23
|
-1,584
|
+18.1%
|
|
1Q23
|
-1,508
|
+17.7%
|
|
4Q22
|
-1,455
|
+20.5%
|
|
3Q22
|
-1,384
|
+16.3%
|
|
2Q22
|
-1,341
|
+18.5%
|
|
1Q22
|
-1,282
|
+17.8%
|
|
4Q21
|
-1,208
|
+18.0%
|
|
3Q21
|
-1,190
|
+23.6%
|
|
2Q21
|
-1,131
|
+23.4%
|
|
1Q21
|
-1,088
|
+23.9%
|
|
4Q20
|
-1,024
|
+21.7%
|
|
3Q20
|
-963
|
+14.9%
|
|
2Q20
|
-917
|
+14.5%
|
|
1Q20
|
-879
|
+15.1%
|
|
4Q19
|
-841
|
+14.8%
|
|
3Q19
|
-839
|
+18.9%
|
|
2Q19
|
-801
|
+18.6%
|
|
1Q19
|
-763
|
+16.2%
|
|
4Q18
|
-732
|
+15.8%
|
|
3Q18
|
-705
|
+15.1%
|
|
2Q18
|
-675
|
+13.0%
|
|
1Q18
|
-657
|
+13.1%
|
|
4Q17
|
-632
|
+11.6%
|
|
3Q17
|
-613
|
+9.0%
|
|
2Q17
|
-598
|
+8.6%
|
|
1Q17
|
-581
|
+8.7%
|
|
4Q16
|
-567
|
+10.8%
|
|
3Q16
|
-562
|
+14.0%
|
|
2Q16
|
-551
|
+15.0%
|
|
1Q16
|
-534
|
+10.5%
|
|
4Q15
|
-511
|
+9.2%
|
|
3Q15
|
-493
|
+8.0%
|
|
2Q15
|
-479
|
+6.9%
|
|
1Q15
|
-484
|
+11.6%
|
|
4Q14
|
-468
|
+10.7%
|
|
3Q14
|
-457
|
+9.3%
|
|
2Q14
|
-448
|
+9.3%
|
|
1Q14
|
-433
|
+9.0%
|
|
4Q13
|
-423
|
+7.7%
|
|
3Q13
|
-418
|
+9.4%
|
|
2Q13
|
-410
|
+10.1%
|
|
1Q13
|
-398
|
+10.4%
|
|
4Q12
|
-393
|
+11.1%
|
|
3Q12
|
-382
|
+12.1%
|
|
2Q12
|
-372
|
+14.1%
|
|
1Q12
|
-360
|
-
|
|
4Q11
|
-354
|
-
|
|
3Q11
|
-341
|
-
|
|
2Q11
|
-326
|
-
|